Rodney S. Markin is listed as a director on 14 SEC Form D filings by 4 issuers between Mar 2015 and Jun 2020: Cardiff Oncology, Inc. (San Diego, CA — biotechnology — 2017–2020; $13.5M reported sold to 40 investors), Paradigm Diagnostics, Inc. (Phoenix, AZ — pharmaceuticals — 2018; $11M reported sold to 12 investors), PerceptiMed, Inc. (Mountain View, CA — other technology — 2015–2018; $5.35M reported sold to 8 investors) and PodPonics, Inc. (Atlanta, GA — agriculture — 2015; $4.55M reported sold to 62 investors).
What this means A repeat sponsor — 4 separate companies raised money with this person listed as director, over about 5 years. Across those companies the filings report $34.4M sold in total.
Listed alongside Gary Jacob (8 shared filings), John Brancaccio (8 shared filings), Thomas Adams (8 shared filings), Athena Countouriotis (4 shared filings), Grace Colon (4 shared filings) and 31 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Rodney. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 bankruptcy cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 14 public filings for Rodney S. Markin and found 8 differences: 4 offerings changed their target amount between filings; 5 offerings have no amendment in the last 12 months and may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.